现成单逆向胸支内移植物用于急性主动脉病变的多中心经验
多中心回顾性研究纳入107例因急性指征行胸支内移植物胸主动脉腔内修复的患者,技术成功率99%,30天死亡率2%,主要不良事件18%,卒中6%,截瘫6%,5%发生逆行夹层,结论认为该装置在急性病变中死亡、卒中和截瘫风险低,需更长期随访评估修复效果。
要点
- 急性指征包括夹层65%、症状性动脉瘤/假性动脉瘤20%、钝性创伤性主动脉损伤15%。
- 30天死亡2%,主要不良事件18%,卒中6%,截瘫6%,逆行夹层5%。
- 技术成功率99%,7%发生IA或III型内漏,10%需再干预。
核心结论
- 急性病变中紧急/急诊使用Gore胸支内移植物行胸主动脉腔内修复的死亡、卒中和截瘫风险低。
- 需要更长期随访评估修复的有效性。
研究设计与样本
- 多中心回顾性研究,回顾7家机构2017年3月至2024年3月接受胸支内移植物胸主动脉腔内修复患者的临床资料、影像和结局。
- 纳入因复杂性主动脉夹层、症状性动脉瘤/假性动脉瘤或钝性创伤性主动脉损伤行紧急/急诊修复的患者。
- 共107例(男性69.0%;平均年龄60±15岁)因急性指征接受修复。
主要发现
- 急性指征包括夹层70例(65%)、症状性动脉瘤/假性动脉瘤21例(20%)、钝性创伤性主动脉损伤16例(15%)。
- 8例(8%)在A型夹层开放升主动脉修复后立即行修复;近端密封区2为91例(89%),0至1区为11例(11%)需颈部去分支。
- 除1例急性夹层伴动脉瘤样变需分期修复外,其余患者技术成功(99%)。
- 30天时2例(2%)死亡,19例(18%)发生主要不良事件,包括卒中6例(6%)和截瘫6例(6%)。
- 5例(5%;均为2区)发生逆行夹层,均因急性或亚急性夹层治疗,无死亡;平均随访55±171天,96例(94%)有随访影像。
临床怎么用
- 作者认为,急性病变中紧急/急诊使用Gore胸支内移植物行胸主动脉腔内修复的死亡、卒中和截瘫风险低。
- 作者指出需要更长期随访评估修复的有效性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The thoracic branch endoprosthesis (TBE) (W.L. Gore) offers an off-the-shelf single option for thoracic endovascular aortic repair (TEVAR) of aortic arch pathology with sealing in zones 0 to 2. This study reports the early outcomes of TBE-TEVAR for acute indications. METHODS: Clinical data, imaging, and outcomes of patients treated with TBE-TEVAR at seven institutions were retrospectively reviewed (March 2017 to March 2024). Patients treated for complicated aortic dissection, symptomatic aneurysm/pseudoaneurysm, or blunt traumatic aortic injury by urgent/emergent repair were included. End points were 30-day mortality, major adverse events (mortality, myocardial infarction, prolonged intubation, stroke, paraplegia, dialysis, or bowel ischemia), and technical success. RESULTS: Of 356 patients treated by TBE-TEVAR, 107 (69.0% male; mean age, 60 ± 15 years) underwent repair for acute indications including 70 dissections (65%), 21 symptomatic aneurysms/pseudoaneurysms (20%), and 16 blunt traumatic aortic injuries (15%). Eight patients (8%) had repair immediately after open ascending repair of a type A dissection. Proximal sealing was in zone 2 in 91 patients (89%) and zone 0 to 1 in 11 patients (11%) who required cervical debranching. Technical success was achieved in all (99%) except one patient with acute dissection and aneurysmal degeneration requiring staged repair. At 30 days, two patients (2%) died, and 19 patients (18%) developed major adverse events, including stroke in six patients (6%) and paraplegia in six patients (6%). Five patients (5%; all Zone 2) had retrograde dissections, all treated for acute or subacute dissection, with no mortality. Mean follow-up was 55 ± 171 days, and 96 patients (94%) had follow-up imaging. Type IA or III endoleak occurred in seven patients (7%), retrograde branch occlusion in one (1%), and eleven (10%) required reintervention. Cumulative aortic-related mortality was three (3%) from aortic rupture. CONCLUSIONS: Urgent/emergent TEVAR with the Gore TBE device in acute pathology offers low mortality, stroke, and paraplegia risk. Longer follow-up is needed to assess effectiveness of the repair.
引用
- DiLosa KL, Manesh M, Kanamori LR, et al. Multi-center experience with an off-the-shelf single retrograde thoracic branch endoprosthesis for acute aortic pathology. J Vasc Surg. 2024. PMID: 39694154. doi:10.1016/j.jvs.2024.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。